| Literature DB >> 32212315 |
Jayati Mookerjee-Basu1, Robert Hooper2,3, Scott Gross2,3, Bryant Schultz2,3, Christina K Go2,3, Elsie Samakai2,3, Jonathan Ladner1, Emmanuelle Nicolas1, Yuanyuan Tian2,4, Bo Zhou2, M Raza Zaidi2,3, Warren Tourtellotte5, Shan He2,4, Yi Zhang2,4, Dietmar J Kappes1, Jonathan Soboloff2,3.
Abstract
While the zinc finger transcription factors EGR1, EGR2, and EGR3 are recognized as critical for T-cell function, the role of EGR4 remains unstudied. Here, we show that EGR4 is rapidly upregulated upon TCR engagement, serving as a critical "brake" on T-cell activation. Hence, TCR engagement of EGR4-/- T cells leads to enhanced Ca2+ responses, driving sustained NFAT activation and hyperproliferation. This causes profound increases in IFNγ production under resting and diverse polarizing conditions that could be reversed by pharmacological attenuation of Ca2+ entry. Finally, an in vivo melanoma lung colonization assay reveals enhanced anti-tumor immunity in EGR4-/- mice, attributable to Th1 bias, Treg loss, and increased CTL generation in the tumor microenvironment. Overall, these observations reveal for the first time that EGR4 is a key regulator of T-cell differentiation and function.Entities:
Keywords: EGR4; K channels; STIM1; Th1 differentiation; cancer immunity
Mesh:
Substances:
Year: 2020 PMID: 32212315 PMCID: PMC7202224 DOI: 10.15252/embr.201948904
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807